Drug Delivery

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?